Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AGRX

Agile Therapeutics (QB) (AGRX)

Agile Therapeutics Inc (QB)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:AGRX
DateTimeSourceHeadlineSymbolCompany
07/16/20244:21PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialUSOTC:AGRXAgile Therapeutics Inc (QB)
07/16/20244:15PMEdgar (US Regulatory)Form 8-K/A - Current report: [Amend]USOTC:AGRXAgile Therapeutics Inc (QB)
07/15/20244:35PMEdgar (US Regulatory)Form 8-K/A - Current report: [Amend]USOTC:AGRXAgile Therapeutics Inc (QB)
07/12/20245:29PMEdgar (US Regulatory)Form PREM14A - Preliminary proxy statements relating to merger or acquisitionUSOTC:AGRXAgile Therapeutics Inc (QB)
07/09/20242:20PMEdgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsUSOTC:AGRXAgile Therapeutics Inc (QB)
05/15/20244:30PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:AGRXAgile Therapeutics Inc (QB)
05/15/20244:15PMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:AGRXAgile Therapeutics Inc (QB)
01/08/20204:32PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:AGRXAgile Therapeutics Inc (QB)
11/18/20195:21PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:AGRXAgile Therapeutics Inc (QB)
11/14/20194:40PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:AGRXAgile Therapeutics Inc (QB)
 Showing the most relevant articles for your search:USOTC:AGRX